Loading…
Rico-Perez Products, Inc. received an FDA Warning Letter on May 18, 2018, regarding violations related to drug products. Based on the limited metadata available, the specific nature of the violations cannot be determined as the subject line is not provided. The letter was issued under FDA authority for drug regulation, though the specific issuing office is not identified in this metadata record. A review of the complete Warning Letter would be necessary to identify the particular compliance issues cited.